Tokyo Metropolitan Institute Of Gerontology is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Tokyo Metropolitan Institute of Gerontology (TMIG) is Japan's premier research institute dedicated to the study of aging and age-related diseases, including neurodegenerative conditions.
Location: Tokyo, Japan
Type: Public Research Institute
Founded: 1974
Parent: Tokyo Metropolitan Government
Website: [tmig.or.jp](https://www.tmig.or.jp)
TMIG conducts comprehensive research on the biological, medical, and social aspects of aging, with particular focus on neurodegenerative diseases that disproportionately affect the elderly.
TMIG's Department of Neurology and Neuroscience conducts extensive research on:
- Alzheimer's Disease: Studies on amyloid-beta metabolism, tau pathology, and therapeutic interventions
- Parkinson's Disease: Research on alpha-synuclein, dopamine neuron degeneration, and Lewy body disease
- Vascular Dementia: Investigation of cerebrovascular contributions to cognitive decline
- Neuroinflammation: Role of microglia and neuroinflammation in neurodegenerative processes
- Geriatric Neuroscience: Understanding age-related changes in brain function
- Molecular Mechanisms of Neurodegeneration: Protein aggregation, oxidative stress, mitochondrial dysfunction
- Biomarker Discovery: Development of early diagnostic markers for neurodegenerative diseases
- Therapeutic Strategies: Drug discovery and novel treatment approaches
- Cognitive Aging: Normal versus pathological cognitive decline in aging populations
- Brain Imaging: Advanced neuroimaging techniques for early detection of neurodegeneration
TMIG houses state-of-the-art research facilities including:
- Animal Research Facility: Specialized facilities for aging mouse models and transgenic Alzheimer models
- Brain Bank: Human brain tissue bank for postmortem studies of neurodegenerative diseases
- Imaging Center: MRI, PET, and advanced microscopy facilities
- Biochemistry Laboratory: Protein analysis and biomarker development
- Pioneering research on tau protein phosphorylation in Alzheimer's disease
- Studies on the role of metal ions in neurodegeneration
- Development of animal models for age-related neurological disorders
- Research on lifestyle factors affecting brain aging
- Discovery of novel biomarkers for early detection of cognitive decline
- Studies on the gut-brain axis and its role in neurodegeneration
TMIG maintains active collaborations with:
- Japanese research universities including University of Tokyo, Kyoto University, and Osaka University
- National Center for Geriatrics and Gerontology (NCGG)
- RIKEN Center for Brain Science
- International research networks on neurodegeneration
- World Health Organization (WHO) on aging and dementia initiatives
TMIG offers various training opportunities:
- Graduate Research Program: Joint programs with Tokyo metropolitan universities
- Postdoctoral Fellowships: Training in gerontology and neurodegeneration research
- Clinical Training: Partnerships with Tokyo Metropolitan Geriatric Hospital
- International Exchange: Visiting researcher programs for international scientists
TMIG is focusing on several emerging research areas:
- Precision Medicine: Developing personalized approaches to dementia prevention and treatment
- Digital Health: Utilizing AI and wearable devices for monitoring cognitive function
- Regenerative Medicine: Stem cell therapies for neurodegenerative conditions
- Multi-omics Approaches: Integrating genomics, proteomics, and metabolomics for biomarker discovery
The study of Tokyo Metropolitan Institute Of Gerontology has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Tokyo Metropolitan Institute of Gerontology. (2024). Research Annual Report 2023. Tokyo Metropolitan Government.
[2] Ihara, Y., et al. (2010). Role of tau protein in Alzheimer's disease. Journal of Alzheimer's Disease, 21(2), 375-384.
[3] Takeda, A., et al. (2018). Zinc homeostasis in the brain in neurodegenerative diseases. Journal of Trace Elements in Medicine and Biology, 48, 221-226.
[4] Matsuda, H. (2019). MRI contributions to the understanding of dementia in Japan. Neuroimaging Clinics, 29(3), 371-380.
[5] Tomimoto, H. (2011). Vascular cognitive impairment: The relationship between small vessel disease and Alzheimer-type pathology. Brain Nerve, 63(11), 1249-1258.
[6] Arai, H. (2022). Current status and future perspectives of dementia research in Japan. Geriatrics & Gerontology International, 22(1), 5-10.
[7] Nakayama, K., et al. (2020). Animal models for Alzheimer's disease: Focus on tau propagation. Neuroscience Research, 156, 34-42.